MedPath

The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole

Not Applicable
Completed
Conditions
Gastroesophageal Reflux
Interventions
Registration Number
NCT04720781
Lead Sponsor
Showa Inan General Hospital
Brief Summary

After vonoprazan (20mg/day) or esomeprazole (20mg/day) for 4weeks is prescribed for patients with erosive esophagitis diagnosed by esophagogastroduodenoscopy, the number of patients who will visit our outpatient clinic again due to some reasons without any appointments is compared with vonoprazan group and esomeprazole.

Detailed Description

1. Patients who have erosive esophagitis diagnosed by esophagogastroduodenoscopy is enrolled.

2. Vonoprazan (20mg/day) or esomeprazole (20mg/day) is prescribed for 4weeks the patients randomly without next appointments.

3. Some patients may visit our outpatient clinic again due to some reasons without any appointments.

4. The number of the patients who revisit our outpatient clinic again is compared with vonoprazan group and esomeprazole.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • outpatients belonging to American Society of Anesthesiologists class I or II
  • patients have erosive esophagitis diagnosed by esophagogastroduodenoscopy shortly before the prescription
Exclusion Criteria
  • other acid blockers are taken

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
VonoprazanVonoprazanVonoprazan (20mg/day) is prescribed for patients with erosive esophagitis
EsomeprazoleEsomeprazoleEsomeprazole (20mg/day) is prescribed for patients with erosive esophagitis
Primary Outcome Measures
NameTimeMethod
The number of patients who revisit our outpatient clinic after the prescription without any appointments3 months

The need to revisit our outpatient clinic again without any appointments may show the patients' satisfaction or dissatisfaction after the prescription of vonoprazan or esomeprazole. The difference in the number between the two groups may show the difference in the effectiveness between the two medicines.

Secondary Outcome Measures
NameTimeMethod
Change of the main symptom with patients after/before medication when the patients revisit again3 months

The ratio of the degree of the main symptom after/before taking the medicine Good 0%- Bad 100%

Trial Locations

Locations (1)

Showa Inan General hospital

🇯🇵

Komagane, Nagano, Japan

© Copyright 2025. All Rights Reserved by MedPath